251 related articles for article (PubMed ID: 18684027)
1. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.
Chetty R
Arch Pathol Lab Med; 2008 Aug; 132(8):1285-9. PubMed ID: 18684027
[TBL] [Abstract][Full Text] [Related]
2. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.
Rindi G; Capella C; Solcia E
Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598
[TBL] [Abstract][Full Text] [Related]
3. Biological and molecular aspects of gastroenteropancreatic neuroendocrine tumors.
Rindi G; Villanacci V; Ubiali A
Digestion; 2000; 62 Suppl 1():19-26. PubMed ID: 10940683
[TBL] [Abstract][Full Text] [Related]
4. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
5. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification.
Klöppel G; Perren A; Heitz PU
Ann N Y Acad Sci; 2004 Apr; 1014():13-27. PubMed ID: 15153416
[TBL] [Abstract][Full Text] [Related]
6. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
Klöppel G
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
[TBL] [Abstract][Full Text] [Related]
7. [Standardization in pathologic diagnosis of gastrointestinal and pancreatic neuroendocrine tumors].
Zheng J
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):793-5. PubMed ID: 21215092
[No Abstract] [Full Text] [Related]
8. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.
Asa SL; La Rosa S; Basturk O; Adsay V; Minnetti M; Grossman AB
Endocr Pathol; 2021 Mar; 32(1):169-191. PubMed ID: 33459926
[TBL] [Abstract][Full Text] [Related]
9. Advances in the cytologic diagnosis of gastroenteropancreatic neuroendocrine neoplasms.
Sigel CS
Cancer Cytopathol; 2018 Dec; 126(12):980-991. PubMed ID: 30485690
[TBL] [Abstract][Full Text] [Related]
10. [Gastroenteropancreatic neuroendocrine neoplasms. Role of biopsies].
Bergmann F
Pathologe; 2013 Nov; 34 Suppl 2():221-5. PubMed ID: 24196617
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic criteria and classification of gastro-intestinal pancreatic endocrine tumors].
Capella C; Uccella S; Albarello L; Feltri M; La Rosa S
Minerva Endocrinol; 2001 Sep; 26(3):103-10. PubMed ID: 11753231
[TBL] [Abstract][Full Text] [Related]
12. Endocrine tumors of the gut and pancreas tumor biology and classification.
Rindi G; Klöppel G
Neuroendocrinology; 2004; 80 Suppl 1():12-5. PubMed ID: 15477709
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Approach to Neuroendocrine Neoplasms of the Gastrointestinal Tract and Pancreas.
Uccella S; Sessa F; La Rosa S
Turk Patoloji Derg; 2015; 31 Suppl 1():113-27. PubMed ID: 26177322
[TBL] [Abstract][Full Text] [Related]
14. Poorly differentiated gastroenteropancreatic neuroendocrine carcinoma associated with X-linked hyperimmunoglobulin M syndrome.
Malhotra RK; Li W
Arch Pathol Lab Med; 2008 May; 132(5):847-50. PubMed ID: 18466034
[TBL] [Abstract][Full Text] [Related]
15. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases.
Schmitt AM; Riniker F; Anlauf M; Schmid S; Soltermann A; Moch H; Heitz PU; Klöppel G; Komminoth P; Perren A
Am J Surg Pathol; 2008 Mar; 32(3):420-5. PubMed ID: 18300808
[TBL] [Abstract][Full Text] [Related]
16. [What is new in the pathology of pancreatic neuroendocrine tumors?].
Komminoth P; Perren A
Pathologe; 2015 May; 36(3):220-8. PubMed ID: 25941099
[TBL] [Abstract][Full Text] [Related]
17. [The ENETS and UICC TNM classification of neuroendocrine tumors of the gastrointestinal tract and the pancreas: comment].
Klöppel G; Rindi G; Perren A; Komminoth P; Klimstra DS
Pathologe; 2010 Sep; 31(5):353-4. PubMed ID: 20809402
[No Abstract] [Full Text] [Related]
18. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
19. Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Conference proceedings. Berlin, Germany, November 3-7, 1993.
Ann N Y Acad Sci; 1994 Sep; 733():1-535. PubMed ID: 7978857
[No Abstract] [Full Text] [Related]
20. [Advances of circulating biomarkers in gastroenteropancreatic neuroendocrine neoplasms].
Chen L; Chen M; Chen J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Mar; 20(3):357-360. PubMed ID: 28338171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
